Age dependency for coagulation parameters in paediatric populations. Results of a multicentre study aimed at defining

Pierre Toulon1, Micheline Berruyer, Marie Brionne-François

  • 1Dr. Pierre Toulon, CHU Nice, Hôpital Pasteur, Service d'Hématologie Biologique, 30, avenue de la Voie Romaine, CS 51069, F-06001 Nice Cedex 1, France, Tel.: + 33 4 92 03 87 09, Fax: + 33 4 92 03 85 95,

Insights

Pediatric coagulation test results vary significantly with age, especially in the first year of life. Establishing age-specific reference ranges is crucial for accurate diagnosis and treatment of bleeding and clotting disorders in children.

Area of Science:

  • Pediatric Hematology
  • Hemostasis and Thrombosis
  • Clinical Coagulation

Background:

  • Developmental hemostasis understanding is vital for managing pediatric hemorrhagic and thrombotic diseases.
  • Coagulation test results are influenced by reagents and analyzers, necessitating laboratory-specific reference ranges.
  • Standardized methods are needed to establish reliable age-dependent reference ranges in pediatric populations.

Purpose of the Study:

  • To establish age-specific reference ranges for coagulation tests in pediatric patients.
  • To evaluate age-related variations in clotting factors, inhibitors, and fibrinolysis markers.
  • To emphasize the importance of age-specific reference ranges for accurate clinical interpretation.

Main Methods:

  • Coagulation tests were performed on plasma samples from 1437 pediatric patients across six age groups.
  • The study utilized standardized reagents and analyzers across seven participating centers.
  • Patient data included age, clinical indication for testing (primarily pre-operative screening), and various coagulation parameters.

Main Results:

  • Prothrombin time (PT) values were comparable to adults, while activated partial thromboplastin time (aPTTT) was longer in younger children.
  • Most clotting factors (except FV), antithrombin, protein C/S, and plasminogen levels were decreased in infants, reaching adult levels by one year.
  • Fibrinogen, Factor VIII (FVIII), von Willebrand factor (VWF), and D-dimer levels were elevated in infants, normalizing within six months to puberty.

Conclusions:

  • Coagulation test results in children are highly age-dependent, particularly during the first year of life.
  • Age-specific reference ranges are essential for the accurate evaluation of hemostasis in pediatric patients.
  • Implementing age-specific ranges improves the diagnosis and management of bleeding and clotting disorders in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
443
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
322
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
311
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
330
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
314
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678